Harmony Biosciences Holdings: Company Investigated by the






Investors can contact the law firm at no cost to learn more about recovering their losses

LOS ANGELES, March 29, 2023 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises Harmony Biosciences Holdings, Inc. (“Harmony Biosciences” or the “Company”) (NASDAQ: HRMY) investors that the firm has initiated an investigation into possible securities fraud and may file a class action on behalf of investors. Harmony Biosciences investors who lost money on their investment are encouraged to contact Lesley Portnoy, Esq.

Investors are encouraged to contact an attorney Lesley F. Portnoyby phone 844-767-8529 or e-mail: [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a free case evaluation and discuss investors’ options for pursuing claims to recover their losses.

On the 28th of March 2023, Scorpion Capital made public a report that asserted that a dozen fatalities took place during the foreign clinical trials of the drug Wakix. In addition, Scorpion Capital claims that the concealment of crucial information from the FDA would have hindered the approval of Wakix. As a result of this report, the value of the Company’s shares experienced a decline.

Please visit us website to review more information and submit your transaction information.

The Portnoy Law Firm represents investors in pursuing claims against causes caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.

Lesley F. Portnoy, Esq.
Admitted CA and NY Bar
[email protected]
310-692-8883
www.portnoylaw.com

Attorney Advertising

You May Also Like

More From Author

+ There are no comments

Add yours